Skip To Main Content
Edoardo Muratore on Muck Rack

Edoardo Muratore

As seen in: Nature, Wiley Online Library, Archives of Disease in Childhood, Frontiers, MDPI, Nutrition Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Edoardo

Contact Edoardo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Gut Microbiome-Immune Interactions During Pediatric Hematopoietic Cell Transplantation: From Conditioning to GvHD Prevention

|
By Marygrace Duggar, Davide Leardini, Edoardo Muratore
| Wiley Online Library Verified
, , , , and , “Gut Microbiome-Immune Interactions During Pediatric Hematopoietic Cell Transplantation: From Conditioning to GvHD Prevention,” Pediatric Transplantation30, no. 6 (2026): e70371, https://doi.org/10.1111/petr.70371. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The authors have nothing to report.
Open in Who Shared Issue with article?

The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation | Bone Marrow Transplantation

|
By Edoardo Muratore, Davide Leardini, Francesco Baccelli
| Nature Verified
Abstract The endothelial activation and stress index (EASIX) score, calculated as [lactate dehydrogenase (LDH; U/L) × serum creatinine (mg/dL)]/platelets (10e9/L)], has been shown to be predictive of nonrelapse mortality (NRM) and endothelial complications in adults receiving allogeneic stem cell transplantation (allo-HSCT); however, definitive results are lacking for children.
Open in Who Shared Issue with article?

Salbutamol safety in children under 2 years of age with acute wheezing: a meta-analysis of randomised controlled trials

|
By Luca Pierantoni, Edoardo Muratore, Sara Cerasi, Daniele Zama
| Archives of Disease in Childhood Verified
Abstract Objective To evaluate the safety of short-term use of inhaled salbutamol in children under 2 years of age with acute wheezing. Data sources Electronic databases (PubMed, Trip, MEDLINE) and the Cochrane Library were searched for studies published up to October 2022. Study selection The search was restricted to randomised controlled trials published in English regarding the safety of inhaled salbutamol in wheezing children under the age of 2.
Open in Who Shared Issue with article?
See all 9 articles